Interstitial lung disease (ILD) is common in systemic sclerosis (SSc) patients and despite
recent advances in the treatment is, at present, the major cause of death. Today, an early …

A subgroup of patients with systemic sclerosis (SSc) develop interstitial lung disease (ILD),
characterized by inflammation and progressive scarring of the lungs that can lead to …

ABSTRACT Introduction: Systemic sclerosis (SSc) is a rare and complex connective tissue
disease characterized by fibrosis of the skin and internal organs. Interstitial lung disease …

Based on international collaborative data, interstitial lung disease is now the most frequent
cause of death in systemic sclerosis (SSc), having supplanted renal crisis in that regard …

Abstract Background Systemic sclerosis (SSc) is a rare connective tissue disease with a
heterogeneous clinical course. Interstitial lung disease (ILD) is a common manifestation of …

Systemic sclerosis (SSc) is a progressive and often devastating disease characterized by
autoimmune dysfunction, vasculopathy, and fibrosis. Interstitial lung disease (ILD) is …

This systematic review summarises current evidence to help guide treatment decisions for
patients with systemic sclerosis (SSc)-associated interstitial lung disease (ILD). A systematic …

Interstitial lung disease (ILD) is a group of lung diseases characterized by thickening of the
interstitium surrounding pulmonary alveolar walls. It is related to specific radiographic …

Treatment for systemic sclerosis-associated interstitial lun... : Current Opinion in
Rheumatology Treatment for systemic sclerosis-associated interstitial lung disease : Current …

Pulmonary disease is the leading cause of morbidity and mortality in patients with systemic
sclerosis (SSc). Recent well-designed trials in SSc-associated interstitial lung disease (SSc …